This content is machine translated Psoriasis vulgaris Patient-adapted biologics therapy – What does the new S3 guideline say? Of particular note is the update to the recommendations on the delivery of systemic therapy. Newly approved active ingredients were integrated, and there is also a special focus on the…
View Post 4 min This content is machine translated Biologics treatment for psoriasis Anti-IL17 therapy over time The fact that IL17 inhibitors are characterized by a rapid onset of action has now been empirically proven several times and is also reflected in a recent head-to-head study. Looking…
View Post 4 min This content is machine translated Diabetic foot ulcer Local wound treatment as an important therapeutic pillar Diabetic foot syndrome is a common and serious complication of diabetes mellitus and contributes to impaired quality of life. Adequate multidisciplinary treatment can reduce these burdens. In addition to regular…
View Post 5 min This content is machine translated Moderate to severe atopic dermatitis Biologic therapy in the changing times: “Best practice” approaches in focus In addition to the new systemic drugs recently launched, several active substances are currently in development. These include some biologics in advanced stages of clinical testing. Overall, the future prospects…
View Post 4 min This content is machine translated Atopic dermatitis JAK inhibition as a mode of action – an update. Janus kinase (JAK) inhibitors are a promising new treatment option for adult patients with atopic eczema, given their rapid relief of pruritus and inflammatory lesions. In addition to baricitinib, which…
View Post 3 min This content is machine translated "Small Molecules" for the Treatment of Psoriasis Oral and topical drug candidates score well in studies As in today’s era of personalized medicine a treatment tailored to the individual needs of psoriasis patients is important, there are several arguments for a use of small molecule substances.…
View Post 12 min This content is machine translated Atopic dermatitis Digital support options for treatment The terms atopic dermatitis, atopic eczema and atopic dermatitis stand for a global skin disease, with children and adolescents being the most frequently affected. In 2020, a systematic review included… CME-Test
View Post 3 min This content is machine translated Apremilast Effective reduction of itching in the context of scalp psoriasis Visible pruritic lesions on the scalp are a major stress factor for many psoriasis patients. Topical preparations are used as first-line therapy, but these are not always effective, especially in…
View Post 3 min This content is machine translated Phase IIa study Tocilizumab for the treatment of Schnitzler syndrome Schnitzler syndrome is a rare autoinflammatory disorder. Core symptoms include chronic, recurrent hives. In particular, for patients who do not respond to anti-IL1 therapy, there is a need for new…
View Post 4 min This content is machine translated The somewhat different knowledge Who was actually… Moriz Kaposi? When Moriz Kaposi first described Kaposi’s sarcoma in 1872, he probably had no idea that this entity would become much more famous in the context of HIV/AIDS. He was much…
View Post 5 min This content is machine translated Psoriatic Arthritis New long-term data on guselkumab published Phase III data on the IL23p19 inhibitor guselkumab demonstrate complete resolution of skin symptoms and positive joint effects in adult patients with active psoriatic arthritis (PsoA) lasting over two years.
